LumiThera Closes Series C Round of Financing
- Wednesday, July 8, 2020, 7:01
- Finance
- Add a comment
SEATTLE, July 8, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has completed its Series C financing. The company raised…